EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Non-crystalline light chain proximal tubulopathy, a morphologically protean entity

Andreas Kousios, Sarah Blakey, Linda Moran, Maria Atta, Rawya Charif, Neill Duncan iD, Andrew Smith iD, Frederick W K Tam, Jeremy B Levy, Aristeidis Chaidos, Candice Roufosse

Nephrology Dialysis Transplantation · 31.10.2023 · 38 (11) · 2576-2588

DOI: 10.1093/ndt/gfad085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 29.04.2023. Verfasst von Andreas Kousios und 10 weiteren Autor:innen. Beteiligte Einrichtung: Imperial College, Centre for Inflammatory Disease, Dept Immunology and Inflammation, Faculty of Medicine, London, UK. Hauptthemen laut MEDLINE: Kidney Diseases, Multiple Myeloma, Renal Insufficiency, Chronic, Paraproteinemias. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health Research, Imperial College Healthcare NHS Trust, Imperial College London.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Light chain proximal tubulopathy (LCPT) is a rare form of paraprotein-related disease, occurring in two main histopathological forms: crystalline and non-crystalline. The clinicopathological features, treatment strategies and outcomes, especially of the non-crystalline form, are not well described.

Methods

We conducted a single-centre retrospective case series of 12 LCPT patients, 5 crystalline and 7 non-crystalline, between 2005 and 2021.

Results

The median age was 69.5 years (range 47–80). Ten patients presented with CKD and significant proteinuria (median estimated glomerular filtration rate of 43.5 ml/min/1.73 m2; urine protein:creatinine ratio 328 mg/mmol). Only six patients had known haematological disease at the time of renal biopsy. Multiple myeloma (MM) was diagnosed in seven patients cases and monoclonal gammopathy of renal significance (MGRS) in five patients. A clone was detected in all cases combining serum/urine electrophoresis and free light chain (LC) assays. Crystalline and non-crystalline variants had similar clinical presentations. For the non-crystalline variant, a diagnosis was reached based on a combination of CKD without another cause, haematological workup, LC restriction on immunofluorescence and abnormalities on electron microscopy (EM). Nine of 12 patients received clone-directed treatment. Patients who achieved haematological response (including all non-crystalline LCPT) had improved renal outcomes over a median follow-up of 79 months.

Conclusions

The non-crystalline variant may go unrecognised because of its subtle histopathological features and requires EM to distinguish it from ‘excessive LC resorption without tubular injury’. Clone-directed treatment with good haematological response improves renal outcomes in both variants but limited data exist in MGRS. Multicentre prospective studies are needed to better define the clinicopathological characteristics associated with poor outcomes and optimize treatment strategies in patients with MGRS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney DiseasesMultiple MyelomaRenal Insufficiency, ChronicParaproteinemiasHumansMiddle AgedAgedAged, 80 and overRetrospective StudiesKidneyImmunoglobulin Light Chains

Stichwörter der Autor:innen

Fanconi syndromechronic kidney diseasemonoclonal gammopathy of renal significancemultiple myelomaproximal tubular cells

Substanzen

Immunoglobulin Light Chains

Autor:innen und Institutionen

  • Imperial College, Centre for Inflammatory Disease, Dept Immunology and Inflammation, Faculty of Medicine, London, UK.
  • West London Renal and Transplant Centre, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • North West London Pathology, Charing Cross Hospital, London, UK.
  • Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, UK.

ORCID-Profile: Neill Duncan, Andrew Smith

Förderung

  • National Institute for Health Research
  • Imperial College Healthcare NHS Trust
  • Imperial College London

Zitieren

APA

Kousios, A., Blakey, S., Moran, L., Atta, M., Charif, R., Duncan, N., Smith, A., Tam, F. W. K., Levy, J. B., Chaidos, A., & Roufosse, C. (2023). Non-crystalline light chain proximal tubulopathy, a morphologically protean entity. Nephrology Dialysis Transplantation, 38(11), 2576-2588. https://doi.org/10.1093/ndt/gfad085

Vancouver

Kousios A, Blakey S, Moran L, Atta M, Charif R, Duncan N, et al. Non-crystalline light chain proximal tubulopathy, a morphologically protean entity. Nephrology Dialysis Transplantation. 2023;38(11):2576-2588. doi:10.1093/ndt/gfad085

BibTeX
@article{Kousios2023,
  author = {Kousios, Andreas and Blakey, Sarah and Moran, Linda and Atta, Maria and Charif, Rawya and Duncan, Neill and Smith, Andrew and Tam, Frederick W K and Levy, Jeremy B and Chaidos, Aristeidis and Roufosse, Candice},
  title = {Non-crystalline light chain proximal tubulopathy, a morphologically protean entity},
  journal = {Nephrology Dialysis Transplantation},
  year = {2023},
  volume = {38},
  number = {11},
  pages = {2576--2588},
  doi = {10.1093/ndt/gfad085}
}
Kostenlos starten →